GB2272222A - Command curable composition - Google Patents

Abstract

A curable composition (e.g. dental cement) comprises (a) a partly esterified phosphonic acid, (b) an initiator (e.g. light or chemical actuator), (c) ion-leachable glass powder or metal oxide, (d) poly(vinyl phosphonic acid) and (e) a compound with at least two vinyl groups. (a) may be the product of vinyl phosphonyl chloride and pentane 1, 5 diol; and (e) may be a photopolymerisable dimethacrylate resin. The composition may comprise water, inert filler and silanising agent. The composition may be formed from two packs, each pack containing some of the components. In use the composition is put in place and, when ready, it is e.g. light-irradiated for 30 or 40 seconds to polymerise (e). The composition is immediately firm and the phosphonate groups adhere to tooth material while further slow curing by acid-base reaction continues.

Description

COMMAND-CURABLE COMPOSITION This invention relates to compositions curable on command, e.g. by the action of incident energy e.g. light (ultraviolet or visible) or ultrasound. Such compositions may contain inert or reactive fillers, in which case they can be classed as cements, and may be particularly useful in surgical, especially dental, applications.

As dental cements, glass ionomers as described in for example GB Patents 1422337 and 1484454 have attained wide popularity for their compressive strength, their inherent adhesion to tooth material, their relatively fast setting time and their anti-caries action. However, a drawback in clinical practice is that, once mixed, the glass ionomer cement composition stays workable for a strictly limited time only, and sets rapidly.

It has been proposed in EP-A-323120 to formulate a glass ionomer with modifying agents to delay its setting, with photocurable characteristics too, so that a photocure can be effected by the dentist when he is ready, with the acid-base glass ionomer reaction proceeding in parallel. However, those formulations having acceptable adhesiveness remain workable for only about five minutes, which could still be too short to deal with unexpected clinical eventualities.

Nonetheless, light-cured glass-ionomer cements have now become widely available for use as lining materials. The photocurable characteristics are supplied by adding, to the glass and polyacid required for the acid-base reaction, polymerisable monomers such as hydroxyethylmethacrylate (HEMA) which participate in the photopolymerisation reaction.

These light-cured glass-ionomers have proved to be very sensitive to the presence of moisture. This is because the set cement has a structure similar to that of a hydrogel. The structure is lightly crosslinked and contains hydrophilic groups, the light-cured methacrylates. Hence the cement has an affinity for water, which, once absorbed, acts as a plasticiser within the materials and reduces the strength of the cement. The water also tends to swell the cement.

It would be desirable to have a command-curable composition which, despite comprising a number of dissimilar chemical compounds, was presented in a stable non-separating common solution.

According to the present invention, a command-curable composition comprises (a) a partly esterified phosphonic acid being equivalent to the reaction product between a precursor of a polyphosphonic acid (e.g. poly(vinyl phosphonic acid)) and an esterifying group such as a polyhydric alcohol in the mole ratio (0.2 - 5.0) phosphonic acid groups: 1 esterifying group, (b) an initiator suitably a light-activated initiator system or a chemical initiator system, (c) cation-leachable glass powder, (d) poly(vinyl phosphonic acid) and (e) a bulky molecule with at least two vinyl groups through which it may cross-link/polymerise. The composition preferably further comprises water.The said mole ratio is preferably (0.5 - 1.5):1 such as (0.8 - 1.2):1. The precursor may be vinyl phosphonic di chloride. The OH groups in the alcohol are preferably interconnected via from two to twenty such as two to six organic backbone (usually carbon atoms), with oxygen atoms optionally interposed at least (preferably) every fifth carbon atom. The bulky molecule may be a dimethacrylate such as a dimethacrylate formed from the reaction between bisphenol A and glycidyl methacrylate.

The cation-leachable (e.g. aluminosilicate) glass powder may be partly or wholly replaced by amphoteric or basic metal oxide (e.g. MgO, which may be de-activated at at least 900 C). By "poly(vinyl phosphonic acid)" we include any multivalent-cation-catalysed cross-linkable polymeric acid containing on average one phosphonic acid group per one to three backbone carbon atoms. A minor proportion of poly(carboxylic acid) such as poly(acrylic acid) may also be present. This composition when mixed together will cure slowly by ionomer (acid-base) reaction between the phosphonic acid groups and the glass/oxide, and rapidly on demand by polymerising (cross-linking) reaction of the bulky molecule when initiated by (b).

The invention extends to a pack comprising the components of said composition (optionally excluding water) so presented as not to react prematurely, for example in the form of two separated pastes which when mixed form a curable composition as set forth above; the first paste may be the acid(s) plus water and the light-activated or ultrasound-activated initiator system, and the second paste may be the glass powder suspended in the dimethacrylate. If the two pastes have been formulated to appropriate concentrations, one could in use squeeze out equal lengths of paste from two tubes, or scoop out equal numbers of spoonfuls from two tubs, as an easy way to ensure that the mixture is of the correct composition.

The glass powder preferably consists of particles substantially all of which are smaller than 100 microns, preferably smaller than 60 microns. The Si:Al atomic ratio range of (0.6 - 2):1 yields an opaque product, which may be acceptable in appropriate cases, but (0.2 - 0.6):1 can also be used.

Also present may be fillers, preferably inert e.g. quartz, and a silanising agent to improve the incorporation of the filler into the cement. The bulky molecule can yield a completely hydrophobic polymer - thus stable against oral fluids - which can however successfully wet glass, improving the coherence of the set cement. The cement can also be compatible/adhesive to tooth material through phosphonate groups in the acid and in the esterified acid, the later being compatible with the bulky molecule yet itself being polar and thus hydophilic. The invention will now be described by way of example.

The components used in the following examples of light-cured, poly(vinyl phosphonic acid) glass ionomer cements are:1. Bis GMA Bis GMA is the main photopolymerisable component in the cement. It is a dimethacrylate resin formed from the reaction between bisphenol A and glycidyl methacrylate.

2. PR PR is the product of reaction between vinyl phosphonyl dichloride and pentane 1,5 diol, as described in EP-A-395427. PR is another photopolymerisable component of the cement, although its degree of photopolymerisation is low for electronic reasons. Within the cement the PR should act as an adhesion promoter, also promoting compatibility and miscibility between the other components of the cement.

3. Initiator This, the photopolymerisation initiator, is made up of camphorquinone (CQ), sodium toluenesulphinate (NaTS) and ethyl p-dimethylaminobenzoate (EDMAB).

The components of the initiator are mixed in the ratio CQ:NaTS:EDMAB=O.3:2.O:O.75.

4. Water Water is required in the cement formulation as the medium for ion transport in the acid-base reaction.

5. PVPA PVPA is the polyacid, poly(vinyl phosphonic acid), used in the cement formulation. It is required for the conventional acid-base reaction in the cement formation.

6. Glass The glass is an ion-leachable aluminosilicate. In the formation of the cement it acts as the base for the acid-base reaction. The glass is prepared by mixing together 437 parts by weight silica, 230 parts by weight alumina, 129 parts by weight calcium fluoride, 175 parts by weight cryolite and 29 parts by weight aluminium phosphate and heating to 1300"C for 75 minutes. The melt is cooled rapidly by pouring into water. The resulting glass is ground and sieved, and the fraction of particle size less than 45 microns used in the composition.

For each example, the same mixing regime was followed: All the components of the cement were weighed out ready.

First the BisGMA and PR were combined on an inert surface. Then the Initiator was mixed in, followed by the Water and then the PVPA. When an homogeneous paste had been formed, the Glass was added as the final component. For the purposes of the determination of working time, time t=O was taken as when the Glass was added.

Layered compressive strength specimens were prepared in 4 x 6 mm moulds; each layer was packed and then irradiated to cure it using dental blue light (35W halogen lamp) as close as possible to the specimen but ensuring that the specimen did not touch the light. The cements were stored in the moulds at 37"C for one hour and then stored in water at 37"C for a further 23 hours. The load at failure in compression was measured using an Instron 1185 with crosshead speed lmm/min, from this value the measured compressive strength can be ascertained.

The duration of the irradiation to cure, the amount used of each component in parts by weight, and the resulting compressive strength in megapascals (with the standard deviation), are shown for each Example in the following table.

Ex No cure BisGMA PR Initr Water PVPA Glass CS (sd) 1 30s 0.13 0.07 0.08 0.05 0.10 0.20 21.70 (2.1) lat 30s 0.13 0.07 0.08 0.05 0.10 0.20 15.76 (1.6) 2 30s 0.13 0.07 0.09 0.05 0.10 0.30 18.30 (4.7) 2at 30s 0.13 0.07 0.09 0.05 0.10 0.30 15.94 (2.6) 3 30s 0.16 0.07 0.08 0.05 0.10 0.20 27.19 (2.3) 4 30s 0.16 0.07 0.08 0.08 0.10 0.20 17.04 (2.0) 5 30s 0.13 0.07 0.08 0.05 0.10 0.30 19.59 (3.1) 6 30s 0.10 0.07 0.08 0.05 0.10 0.20 9.78 (1.8) 7 40s 0.13 0.07 0.06 0.05 0.10 0.20 17.97 (2.0) 8 40s 0.13 0.07 0.06 0.05 0.10 0.30 33.58 (5.3) 9 30s 0.16 0.07 0.08 0.05 0.10 0.30 23.10 (4.9) 10 30s 0.16 0.07 0.08 0.05 0.10 0.40 30.90 (3.3) 10a 40s 0.16 0.07 0.08 0.05 0.10 0.40 34.53 (4.9) 11 30s 0.16 0.07 0.08 0.05 0.10 0.45 29.00 (7.5) lla 30s 0.16 0.07 0.08 0.05 0.10 0.45 30.60 (2.6) llb 40s 0.16 0.07 0.08 0.05 0.10 0.45 31.45 (3.2) 12 30s 0.16 0.07 0.08 0.05 0.10 0.50 30.98 (6.1) 12a 40s 0.16 0.07 0.08 0.05 0.10 0.50 32.92 (3.9) 13 30s 0.13 0.07 0.08 0.075 0.15 0.45 23.28 (3.3) 14 30s 0.13 0.07 0.08 0.075 0.15 0.55 26.44 (1.6) 15 30s 0.20 0.07 0.08 0.05 0.10 0.55 38.67* (4.0) 15a 40s 0.20 0.07 0.08 0.05 0.10 0.55 41.74V (4.6) 15b≈30s 0.20 0.07 0.08 0.05 0.10 0.55 34.87 (5.0) Notes t - stored in air - storage: in mould 37"C 1 hr; in moist atmosphere 37"C for further 23 hrs; in water 37"C for next 24 hrs e - high value recorded 43.34MPa * - high value recorded 45.83 MPa V - high value recorded 49.67 MPa The wide variation in these compressive strength values may be due to various extraneous factors, such as the difficulty in consistently packing layers in the mould (specimens yielding lower strengths when there were obvious flaws in the sides of the specimen) and the time elapsed between mixing and placing, and irradiating, during which time a glass ionomer matrix may have formed to a sufficient extent to impede formation of the polymerisation matrix. If this is the case then the two matrix forming reactions are in competition.Consequently it is possible that difference layers within the same cement may have different proportions of acid-base and polymerisation matrices and hence different strengths.

The presence of PVPA (preferably at least 1l/4, e.g. at least twice, the mass of the water) and of the PR should improve the adhesion of the cement to tooth material. BisGMA undergoes the main light-induced polymerisation and is used in this formulation because it has a good percentage conversion on illumination and also because as a result of its bulky size the hydrophilicity and polymerisation shrinkage are small.

Effect of BisGMA Comparing Examples 1, 3 and 6 shows that increasing the levels of BisGMA increased the strength of the cement. It was preferably at least 11/2 times, more preferably at least twice the mass of the PVPA.

Effect of Level of Initiator It is important that the level of initiator be as low as possible in the cement, otherwise the components of the initiator can leach our from the set cement and cause a cytotoxic response. A reduction in the level of initiator may need to be accompanied by an increase in irradiation time, which is allowable provided that the longer irradiation time is still acceptable clinically. Examples 1, 2 and 7 suggest an optimum around 13% by mass of initiator, which is high.

Effect of Cure Time Increasing the cure time of the material did not appear to cause a statistically significant increase in strength for Examples 10/low, ll/llb, 12/12a nor 15/15a. This would imply that for these materials the 30 seconds' cure time is sufficient.

Effect of Level of Glass The glass acts as both the filler in the photopolymerisation reaction and the base in the acid-base reaction. While increasing the level of glass in the system should improve the strength of the cement, Examples 9, 10, 11 and 12 show a trend which is not significant statistically. Glass was preferably more than four, more preferably more than five, times the mass of the PVPA, especially advantageously with high bisGMA.

BisGMA, being a dimethacrylate resin formed from the reaction between bisphenol A and glycidyl methacrylate, has the structure

Hydroxyethylmethacrylate (HEMA), a significantly smaller molecule, has the structure

- Both are polymerised through the vinyl (CH2=C < ) group.

Dimethacrylates such as bisGMA give crosslinked polymers, while HEMA forms linear polymers which may however show branching.

Claims (16)

Claims

1. A command-curable composition comprising (a) a partly esterified phosphonic acid being equivalent to the reaction product between a precursor of a polyphosphonic acid and an esterifying group in the mole ratio (0.2-0.5) phosphonic acid groups : 1 esterifying group, (b) an initiator, (c) cation-leachable glass powder and/or amphoteric or basic metal oxide, (d) poly(vinyl phosphonic acid) and (e) a bulky molecule with at least two vinyl groups through which it may cross-link/polymerise.

2. A command-curable composition according to Claim 1, further comprising water.

3. A command-curable composition according to Claim 1 or 2, wherein the partly esterified acid (a) is equivalent to the reaction product between a precursor of poly(vinyl phosphonic acid) and an esterifying group.

4. A command-curable composition according to any preceding claim, wherein the said esterifying group is a polyhydric alcohol.

5. A command-curable composition according to Claim 4, wherein the OH groups in the alcohol are interconnected via from two to twenty organic backbone atoms.

6. A command-curable composition according to Claim 5, wherein the OH groups in the alcohol are interconnected via carbon atoms with oxygen atoms interposed at least every fifth carbon atom.

7. A command-curable composition according to any preceding claim, wherein the said mole ratio is (0.5-1.5):1.

8. A command-curable composition according to Claim 7, wherein the said mole ratio is (0.8-1.2):1.

9. A command-curable composition according to any preceding claim, wherein the said precursor is vinyl phosphonic dichloride.

10. A command-curable composition wherein component (c) is aluminosilicate glass powder.

11. A command-curable composition according to Claim 10, wherein the glass powder (c) has an Si:Al atomic ratio of (0.2-0.6):1 or (0.6-2):1.

12. A command-curable composition according to any preceding claim wherein the glass powder consists of particles substantially all of which are smaller than 100 microns.

13. A command-curable composition according to any of Claims 1 to 9, wherein component (c) is MgO deactivated at at least 9000C.

14. A command-curable composition according to any preceding claim, wherein the bulky molecule (e) is a dimethacrylate.

15. A command-curable composition according to any preceding claim, further comprising a filler and/or a silanising agent.

16. A pack comprising all the components of a composition according to any preceding claims, so presented as not to react prematurely.